Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: AstraZeneca 15.288, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
AstraZeneca vs CSL Net Worth and Market Cap
AstraZeneca (AZN) and CSL (CSL.AX) are peers in Vaccines. AstraZeneca reported revenue of $15.3B as of Q1 2026, compared with $7.3B for CSL. AstraZeneca leads on revenue.
AstraZeneca's gross margin is 82.5% versus 44.4% for CSL. AstraZeneca's net margin is 20.1% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, AstraZeneca, CSL.| Metric | AstraZeneca | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.29B | $7.30B |
| Cost of Revenue | $2.68B | $4.06B |
| Gross Profit | $12.61B | $3.24B |
| Operating Income | $4.25B | $1.39B |
| Net Income | $3.08B | $-2.94B |
| R&D Expense | $3.49B | $614.00M |
| Earnings Per Share | $1.97 | -$6.14 |
| Gross Margin | 82.5% | 44.4% |
| Operating Margin | 27.8% | 19.0% |
| Net Profit Margin | 20.1% | -40.2% |
| Free Cash Flow | $1.82B | $1.76B |
| Cumulative Free Cash Flow | $120.67B | $21.56B |
| Operating Cash Flow | $3.36B | $2.09B |
| Cash & Equivalents | $7.56B | $1.51B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.